First medicine to treat rare genetic disorder causing cysts and tumours

View source ↗

Summary

The European Medicines Agency approved belzutifan (brand name Welireg) as the first medicine to treat von Hippel-Lindau disease and advanced clear cell renal ce…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Renal Cell Carcinoma
• Von Hippel-lindau Disease

Drugs mentioned

• Welireg (belzutifan)

Snippet

Oral medicine to treat two different conditions, rare von Hippel-Lindau disease and advanced clear cell renal cell carcinoma